Galecto logo

Galecto Share Price Today

(NASDAQ: GLTO)

Galecto share price is $4.93 & ₹426.90 as on 31 Jan 2025, 2.30 'hrs' IST

$4.93

-0.17

(-3.24%)

Market is closed - opens 8 PM, 31 Jan 2025

View live Galecto share price in Dollar and Rupees. Guide to invest in Galecto stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Galecto, along with analyst recommendations, forecasts, and comprehensive financials.

Galecto share price movements

  • Today's Low: $4.77
    Today's High: $5.12

    Day's Volatility :6.84%

  • 52 Weeks Low: $4.40
    52 Weeks High: $23.50

    52 Weeks Volatility :81.27%

Galecto (GLTO) Returns

PeriodGalecto IncIndex (Russel 2000)
3 Months
-26.96%
0.0%
6 Months
-62.37%
0.0%
1 Year
-68.99%
0.0%
3 Years
-92.05%
-12.8%

Galecto (GLTO) Key Statistics

in dollars & INR

Previous Close
$5.095
Open
$5.09
Today's High
$5.12
Today's Low
$4.77
Market Capitalization
$6.7M
Today's Volume
$12.8K
52 Week High
$23.5
52 Week Low
$4.4006
Revenue TTM
$0.0
EBITDA
$-20.1M
Earnings Per Share (EPS)
$-19.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-72.61%

How to invest in Galecto Stock (GLTO) from India?

It is very easy for Indian residents to invest directly in Galecto from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galecto stock in both Indian Rupees (INR) and US Dollars (USD). Search for Galecto or GLTO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galecto or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galecto shares which would translate to 0.176 fractional shares of Galecto as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Galecto, in just a few clicks!

Returns in Galecto (GLTO) for Indian investors in Rupees

The Galecto stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Galecto investment value today

Current value as on today

₹35,368

Returns

₹64,632

(-64.63%)

Returns from Galecto Stock

₹68,994 (-68.99%)

Dollar Returns

₹4,362 (+4.36%)

Indian investors sentiment towards Galecto (GLTO)

0%

Period: Dec 31, 2025 to Jan 30, 2025. Change in 30 Days versus previous period

Search interest for Galecto Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Galecto

    Analyst Recommendation on Galecto

    Buy

      75%Buy

      25%Hold

      0%Sell

    Based on 8 Wall street analysts offering stock ratings for Galecto(by analysts ranked 0 to 5 stars)

    Based on 8 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    6
    6
    6
    Hold
    2
    2
    3
    Sell
    0
    0
    0

    Analyst Forecast on Galecto Stock (GLTO)

    What analysts predicted

    Upside of 102.84%

    Target:

    $10.00

    Current:

    $4.93

    Insights on Galecto Stock (Ticker Symbol: GLTO)

    • Price Movement

      In the last 7 days, GLTO stock has moved down by -12.3%
    • GLTO vs ALNY (1 yr)

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.3% return, outperforming this stock by 128.1%
    • GLTO vs ALNY (3 yr)

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 101.4% return, outperforming this stock by 193.2%

    Galecto Technicals Summary

    Sell

    Neutral

    Buy

    Galecto is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

    Galecto (GLTO) Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Galecto Inc logo
    -13.51%
    -62.37%
    -68.99%
    -92.05%
    -98.69%
    Biontech Se logo
    4.84%
    47.4%
    27.9%
    -32.69%
    299.34%
    Regeneron Pharmaceuticals, Inc. logo
    -4.49%
    -36.88%
    -28.68%
    11.37%
    100.25%
    Vertex Pharmaceuticals Incorporated logo
    8.04%
    -11.34%
    1.04%
    78.46%
    90.19%
    Alnylam Pharmaceuticals, Inc. logo
    18.64%
    1.88%
    58.45%
    91.24%
    141.72%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Galecto Inc logo
    NA
    NA
    NA
    -15.59
    -0.73
    -0.34
    NA
    16.7
    Biontech Se logo
    160.8
    NA
    0.04
    -3.32
    -0.02
    -0.01
    NA
    79.73
    Regeneron Pharmaceuticals, Inc. logo
    17.01
    17.01
    1.06
    45.08
    0.17
    0.07
    NA
    272.04
    Vertex Pharmaceuticals Incorporated logo
    32.84
    NA
    1.16
    0.49
    -0.03
    0.12
    NA
    60.65
    Alnylam Pharmaceuticals, Inc. logo
    NA
    NA
    -0.49
    -0.18
    -15.01
    -0.03
    NA
    0.25
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Galecto Inc logo
    Buy
    $6.7M
    -98.69%
    NA
    0.0%
    Biontech Se logo
    Buy
    $29.0B
    299.34%
    160.8
    -15.36%
    Regeneron Pharmaceuticals, Inc. logo
    Buy
    $75.5B
    100.25%
    17.01
    33.61%
    Vertex Pharmaceuticals Incorporated logo
    Buy
    $113.7B
    90.19%
    32.84
    -4.51%
    Alnylam Pharmaceuticals, Inc. logo
    Buy
    $35.3B
    141.72%
    NA
    -15.86%

    About Galecto

    Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
    Organization
    Galecto
    Employees
    13
    CEO
    Dr. Hans T. Schambye M.D., Ph.D.
    Industry
    Health Technology

    Management People of Galecto

    NameTitle
    Dr. Hans T. Schambye M.D., Ph.D.
    Co-Founder, President, CEO & Director
    Mr. Garrett Winslow Esq.
    Senior VP, General Counsel & Corporate Secretary
    Mr. Ulf J. Nilsson
    Co-Founder
    Dr. Hakon Leffler
    Co-Founder
    Prof. Tariq Sethi B.Sc., FRCP, M.A., M.D., Ph.D.
    Co-Founder
    Ms. Lori C. Firmani
    Interim Chief Financial Officer

    Important FAQs about investing in GLTO Stock from India :

    What is Galecto share price today?

    Galecto share price today stands at $4.93, Open: $5.09 ; Previous Close: $5.10 ; High: $5.12 ; Low: $4.77 ; 52 Week High: $23.50 ; 52 Week Low: $4.40.

    The stock opens at $5.09, after a previous close of $5.10. The stock reached a daily high of $5.12 and a low of $4.77, with a 52-week high of $23.50 and a 52-week low of $4.40.

    Can Indians buy Galecto shares?

    Yes, Indians can invest in the Galecto (GLTO) from India.

    With INDmoney, you can buy Galecto at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Galecto at zero transaction cost.

    How can I buy Galecto shares from India?

    It is very easy to buy Galecto from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Galecto (GLTO) be purchased?

    Yes, you can buy fractional shares of Galecto with INDmoney app.

    What are the documents required to start investing in Galecto stocks?

    To start investing in Galecto, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Galecto Stock (GLTO)?

    Today’s highest price of Galecto (GLTO) is $5.12.

    Today’s lowest price of Galecto (GLTO) is $4.77.

    What is today's market capitalisation of Galecto?

    Today's market capitalisation of Galecto GLTO is 6.7M

    What is the 52 Week High and Low Range of Galecto Stock (GLTO)?

    • 52 Week High

      $23.50

    • 52 Week Low

      $4.40

    What are the historical returns of Galecto (GLTO)?

    • 1 Month Returns

      -13.51%

    • 3 Months Returns

      -62.37%

    • 1 Year Returns

      -68.99%

    • 5 Years Returns

      -98.69%

    Who is the Chief Executive Officer (CEO) of Galecto ?

    Dr. Hans T. Schambye M.D., Ph.D. is the current Chief Executive Officer (CEO) of Galecto.